Experiment: 7X5C

SOLUTION NMR

NMR Experiment
Experiment	Type	Sample Contents	Solvent	Ionic Strength	pH	Pressure	Temperature (K)	Spectrometer
1	2D 1H-15N HSQC	0.5 mM [U-100% 13C; U-100% 15N] p75OB1-p50PBM, 20 mM phosphate buffer, 300 mM sodium chloride, 2 mM DTT, 2 mM benzamidine, 0.5 mM PMSF, 1 % v/v inhibitor cocktail, 0.03 % NaN3	90% H2O/10% D2O	300 mM	7.0	1 atm	298	Agilent DD2 800
2	2D 1H-13C HSQC	0.5 mM [U-100% 13C; U-100% 15N] p75OB1-p50PBM, 20 mM phosphate buffer, 300 mM sodium chloride, 2 mM DTT, 2 mM benzamidine, 0.5 mM PMSF, 1 % v/v inhibitor cocktail, 0.03 % NaN3	90% H2O/10% D2O	300 mM	7.0	1 atm	298	Agilent DD2 800
3	2D 1H-13C HSQC aromatic	0.5 mM [U-100% 13C; U-100% 15N] p75OB1-p50PBM, 20 mM phosphate buffer, 300 mM sodium chloride, 2 mM DTT, 2 mM benzamidine, 0.5 mM PMSF, 1 % v/v inhibitor cocktail, 0.03 % NaN3	90% H2O/10% D2O	300 mM	7.0	1 atm	298	Agilent DD2 800
4	3D HNCO	0.5 mM [U-100% 13C; U-100% 15N] p75OB1-p50PBM, 20 mM phosphate buffer, 300 mM sodium chloride, 2 mM DTT, 2 mM benzamidine, 0.5 mM PMSF, 1 % v/v inhibitor cocktail, 0.03 % NaN3	90% H2O/10% D2O	300 mM	7.0	1 atm	298	Agilent DD2 600
5	3D HNCACO	0.5 mM [U-100% 13C; U-100% 15N] p75OB1-p50PBM, 20 mM phosphate buffer, 300 mM sodium chloride, 2 mM DTT, 2 mM benzamidine, 0.5 mM PMSF, 1 % v/v inhibitor cocktail, 0.03 % NaN3	90% H2O/10% D2O	300 mM	7.0	1 atm	298	Agilent DD2 600
9	3D CBCA(CO)NH	0.5 mM [U-100% 13C; U-100% 15N] p75OB1-p50PBM, 20 mM phosphate buffer, 300 mM sodium chloride, 2 mM DTT, 2 mM benzamidine, 0.5 mM PMSF, 1 % v/v inhibitor cocktail, 0.03 % NaN3	90% H2O/10% D2O	300 mM	7.0	1 atm	298	Agilent DD2 600
8	3D HNCACB	0.5 mM [U-100% 13C; U-100% 15N] p75OB1-p50PBM, 20 mM phosphate buffer, 300 mM sodium chloride, 2 mM DTT, 2 mM benzamidine, 0.5 mM PMSF, 1 % v/v inhibitor cocktail, 0.03 % NaN3	90% H2O/10% D2O	300 mM	7.0	1 atm	298	Agilent DD2 600
7	3D HN(CO)CA	0.5 mM [U-100% 13C; U-100% 15N] p75OB1-p50PBM, 20 mM phosphate buffer, 300 mM sodium chloride, 2 mM DTT, 2 mM benzamidine, 0.5 mM PMSF, 1 % v/v inhibitor cocktail, 0.03 % NaN3	90% H2O/10% D2O	300 mM	7.0	1 atm	298	Agilent DD2 600
6	3D HNCA	0.5 mM [U-100% 13C; U-100% 15N] p75OB1-p50PBM, 20 mM phosphate buffer, 300 mM sodium chloride, 2 mM DTT, 2 mM benzamidine, 0.5 mM PMSF, 1 % v/v inhibitor cocktail, 0.03 % NaN3	90% H2O/10% D2O	300 mM	7.0	1 atm	298	Agilent DD2 600
13	3D HCCH-TOCSY	0.5 mM [U-100% 13C; U-100% 15N] p75OB1-p50PBM, 20 mM phosphate buffer, 300 mM sodium chloride, 2 mM DTT, 2 mM benzamidine, 0.5 mM PMSF, 1 % v/v inhibitor cocktail, 0.03 % NaN3	90% H2O/10% D2O	300 mM	7.0	1 atm	298	Agilent DD2 800
12	3D HCCH-TOCSY	0.5 mM [U-100% 13C; U-100% 15N] p75OB1-p50PBM, 20 mM phosphate buffer, 300 mM sodium chloride, 2 mM DTT, 2 mM benzamidine, 0.5 mM PMSF, 1 % v/v inhibitor cocktail, 0.03 % NaN3	90% H2O/10% D2O	300 mM	7.0	1 atm	298	Agilent DD2 800
11	3D 1H-15N NOESY	0.5 mM [U-100% 13C; U-100% 15N] p75OB1-p50PBM, 20 mM phosphate buffer, 300 mM sodium chloride, 2 mM DTT, 2 mM benzamidine, 0.5 mM PMSF, 1 % v/v inhibitor cocktail, 0.03 % NaN3	90% H2O/10% D2O	300 mM	7.0	1 atm	298	Agilent DD2 800
10	3D 1H-13C NOESY aliphatic	0.5 mM [U-100% 13C; U-100% 15N] p75OB1-p50PBM, 20 mM phosphate buffer, 300 mM sodium chloride, 2 mM DTT, 2 mM benzamidine, 0.5 mM PMSF, 1 % v/v inhibitor cocktail, 0.03 % NaN3	90% H2O/10% D2O	300 mM	7.0	1 atm	298	Agilent DD2 800
15	3D 1H-13C NOESY aromatic	0.5 mM [U-100% 13C; U-100% 15N] p75OB1-p50PBM, 20 mM phosphate buffer, 300 mM sodium chloride, 2 mM DTT, 2 mM benzamidine, 0.5 mM PMSF, 1 % v/v inhibitor cocktail, 0.03 % NaN3	90% H2O/10% D2O	300 mM	7.0	1 atm	298	Agilent DD2 800

NMR Spectrometer Information
Spectrometer	Manufacturer	Model	Field Strength
1	Agilent	DD2	800
2	Agilent	DD2	600

NMR Refinement
Method	Details	Software
simulated annealing		CNS

NMR Ensemble Information
Conformer Selection Criteria	structures with the lowest energy
Conformers Calculated Total Number	100
Conformers Submitted Total Number	20
Representative Model	1 (lowest energy)

Computation: NMR Software
#	Classification	Version	Software Name	Author
1	collection	VnmrJ	4.1	Agilent
2	processing	NMRPipe		Delaglio, Grzesiek, Vuister, Zhu, Pfeifer and Bax
7	processing	MddNMR		Orekhov, V.Y.
3	data analysis	NMRFAM-SPARKY		Lee,W., Tonelli, M., & Markley, J.L.
6	chemical shift assignment	I-PINE		Lee, Bahrami, Dashti, Eghbalnia, Tonelli, Westler and Markley
4	structure calculation	CYANA		Guntert, Mumenthaler and Wuthrich
5	refinement	CNS		Brunger, Adams, Clore, Gros, Nilges and Read

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.